Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cells
Toshiaki Yoshikawa(Aichi Cancer Center), Yuki Kagoya(Institute for Advanced Medical Research)
Cited by 20
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|299
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity
|Journal of Clinical Investigation|2014|216
BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models
|Journal of Clinical Investigation|2016|214
DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models
|Nature Communications|2018|29